About the Authors

Leslie Goo

Affiliation Viral Pathogenesis Section, National Institutes of Health, Bethesda, MD, United States of America

Laura A. VanBlargan

Affiliation Departments of Medicine, Molecular Microbiology, Pathology & Immunology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, United States of America

Kimberly A. Dowd

Affiliation Viral Pathogenesis Section, National Institutes of Health, Bethesda, MD, United States of America

Michael S. Diamond

Affiliation Departments of Medicine, Molecular Microbiology, Pathology & Immunology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, United States of America

Theodore C. Pierson

piersontc@mail.nih.gov

Affiliation Viral Pathogenesis Section, National Institutes of Health, Bethesda, MD, United States of America

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceptualization: LG LAV KAD MSD TCP. Formal analysis: LG LAV. Funding acquisition: MSD TCP. Investigation: LG LAV. Methodology: LG LAV KAD MSD TCP. Supervision: MSD TCP. Validation: LG LAV MSD TCP. Visualization: LG. Writing – original draft: LG TCP. Writing – review & editing: LG LAV KAD MSD TCP.